Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.960
-0.030 (-0.75%)
At close: Mar 27, 2026

HKG:2185 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
44.93----
Cost of Revenue
26.92----
Gross Profit
18.02----
Selling, General & Admin
27.8219.7452.8894.37195.42
Research & Development
61.8941.3111.74157.83214.23
Operating Expenses
89.7161.04164.62252.2409.65
Operating Income
-71.69-61.04-164.62-252.2-409.65
Interest Expense
-8.74-0.06-0.58-0.96-0.69
Interest & Investment Income
-1.1144.010.97
Earnings From Equity Investments
-1.47-0.99-1.63-1.43-
Currency Exchange Gain (Loss)
-0.921.7318.68-6.61
Other Non Operating Income (Expenses)
-14.10.390.911.046.15
EBT Excluding Unusual Items
-96-59.68-160.2-230.87-409.83
Gain (Loss) on Sale of Investments
--32.170.47--
Gain (Loss) on Sale of Assets
--1.47-30.51-0-
Other Unusual Items
--1.42--
Pretax Income
-96-93.32-188.82-230.87-409.83
Income Tax Expense
-27.57----
Earnings From Continuing Operations
-68.43-93.32-188.82-230.87-409.83
Minority Interest in Earnings
-1.625.3812.9326.6348.38
Net Income
-70.05-87.94-175.89-204.24-361.45
Net Income to Common
-70.05-87.94-175.89-204.24-361.45
Shares Outstanding (Basic)
242243243244221
Shares Outstanding (Diluted)
242243243244221
Shares Change (YoY)
-0.76%--0.14%10.50%61.54%
EPS (Basic)
-0.29-0.36-0.72-0.84-1.64
EPS (Diluted)
-0.29-0.36-0.72-0.84-1.64
Free Cash Flow
--166.69-66.74-170.65-122.75
Free Cash Flow Per Share
--0.69-0.27-0.70-0.56
Gross Margin
40.10%----
Operating Margin
-159.56%----
Profit Margin
-155.91%----
EBITDA
-64.9-54.25-148.21-237.34-400.88
EBITDA Margin
-144.45%----
D&A For EBITDA
6.796.7916.4114.878.77
EBIT
-71.69-61.04-164.62-252.2-409.65
EBIT Margin
-159.56%----
Source: S&P Global Market Intelligence. Standard template. Financial Sources.